All filters
Abstracts
Concentration-QTcF modelling and drug-drug interaction of Bedaquiline, Pretomanid and Clofazimine in TB patients.
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Incidence and determinants of linezolid toxicity in patients with drug-resistant tuberculosis in a high HIV prevalence setting
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
A model-guided weight-banded dosing strategy for once daily delamanid in children
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
A model-based analysis of bedaquiline-related QTcF prolongation in the PROBeX study
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
A Population Pharmacokinetic Model of Linezolid enabling Model-Informed Precision Dosing in Resistant Tuberculosis Patients
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Cerebrospinal Fluid Concentrations of New and Repurposed Drugs among Patients with Tuberculosis Meningitis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Evaluating the effect of clofazimine against Mycobacterium tuberculosis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Exposure-response relationship for bedaquiline, delamanid, and their metabolites
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Investigating the treatment shorting potential of sutezolid-containing regimens in a murine model with confirmed drug exposures
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Operational Challenges with Centralising PK Bioanalysis in a Multicentre Multinational Randomised Controlled Trial
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Optimized loading period strategies for bedaquiline at the restart of drug-resistant tuberculosis treatment
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pentamidine shows promising activity against M. tuberculosis and M. avium complex but not M. abscessus
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pharmacokinetics of linezolid in Indian patients with multidrug-resistant tuberculosis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pharmacokinetics of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
PLASMA BEDAQUILINE LEVELS IN INDIAN MDR-TB PATIENTS
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Population pharmacokinetics of cycloserine, administered as terizidone, in South African children treated for rifampicin-resistant tuberculosis.
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Population Pharmacokinetic Modeling of Pretomanid Dispersible-Tablet Formulation in Healthy Volunteers
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pravastatin pharmacokinetics when administered simultaneously with first-line tuberculosis treatment
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Rifampin Urine Colorimetry for Evaluation of Tuberculosis Pharmacokinetics
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Simulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapy
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveys
A. Abutidze Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, Georgia
L. Sharvadze Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine
Z. Islam Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Dynamics and peculiarities of AIDS mortality in Minsk, Belarus
M. Shylava Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021